logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Biogen Chesapeake LLC

Calculating rank
USPTO Granted Patents = 13



Forward Citations = 30

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Sven Jacobson (13 out of 42 patents)

silverMedal Robert Ang (3 out of 3 patents)

bronzeMedal J Marc Simard (1 out of 16 patents)

4.  Gillian Clarke (1 out of 1 patent)

5.  Rajinder Matharu (1 out of 1 patent)

6.  Thomas W Macallister (1 out of 6 patents)


13 patents:

1. 11559481 - Methods of intravenous administration of glyburide (2023-01-24),
2. 11304963 - Methods of medical treatment with SUR1-TRPM4 channel inhibitors (2022-04-19),
3. 10900040 - Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells (2021-01-26),
4. 10869835 - Formulations and methods for lyophilization and lyophilates provided thereby (2020-12-22),
5. 10786445 - Methods of intravenous administration of glyburide (2020-09-29),
6. 10758503 - Composition containing glibenclamide (2020-09-01),
7. 10688111 - Liquid formulations of compounds active at sulfonylurea receptors (2020-06-23),
8. 10441556 - Composition containing glibenclamide (2019-10-15),
9. 10426729 - Formulations and methods for lyophilization and lyophilates provided thereby (2019-10-01),
10. 10391053 - Methods of intravenous administration of glyburide (2019-08-27),
11. 10117834 - Formulations and methods for lyophilization and lyophilates provided thereby (2018-11-06),
12. 10052280 - Methods of intravenous administration of glyburide (2018-08-21),
13. 10004703 - [object Object] (2018-06-26),
Company Overview
Biogen Chesapeake LLC, based in Cambridge, MA, is a prominent biotechnology company focused on the development and manufacturing of innovative therapies for neurological and neurodegenerative diseases. The organization specializes in research areas such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease, leveraging advanced scientific techniques to address unmet medical needs. With a commitment to improving patient outcomes, Biogen Chesapeake plays a vital role in the biopharmaceutical landscape, contributing to advancements in treatment options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#193 in Cambridge, MA

#1,443 in Massachusetts

#23,863 in US

#45,104 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Biogen Chesapeake LLC

Forward Citations = 30

4 inventors:

goldMedal Sven Jacobson (13 out of 42 patents)

silverMedal Robert Ang (3 out of 3 patents)

bronzeMedal J Marc Simard (1 out of 16 patents)

4.  Gillian Clarke (1 out of 1 patent)

5.  Rajinder Matharu (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biogen Chesapeake LLC. Retrieved from https://idiyas.com/company/biogen-chesapeake

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…